According to this market research, sales revenue of Meropenem in the Chinese market has an increasing trend from 2016 to 2019. In 2020, the sales revenue of Meropenem in China was CNY1.88 billion, which decreased 12.2% Year on Year. The main reason is that the COVID-19 epidemic has impacted the hospitals’ overall operation. The CAGR of the sales value of Meropenem in China is 2% from 2016 to 2020.
The analyst analyzes that as the epidemic situation has been improved and the hospitals resume their operation, sales of Meropenem will have a recovery growth from 2021 to 2025. In addition, the strict limits on the usage of antibiotic drugs and the emergence of drug resistance have driven the demand for more effective antibacterial drugs. Therefore, Meropenem, as a new generation of antibacterial drugs, has the potential to expand its sales in the future.
- The impact of COVID-19 on China's Meropenem market
- Sales value and volume of China's Meropenem 2016-2020
- Competitive landscape of China's Meropenem market
- Prices of Meropenem in China
- Prices of Meropenem in China by regions and manufacturers
- Analysis of factors affecting the development of China's Meropenem market
- Prospect of China's Meropenem market from 2021 to 2025
1.1 Indications for Meropenem
1.2 Development of Meropenem in China
1.3 Governmental Approval of Meropenem in China
1.4 The Impact of COVID-19 on Meropenem sales in China
2 Sales of Meropenem in China, 2016-2020
2.1 Sales Value of Meropenem
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Meropenem
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Meropenem by Dosage Form in China, 2016-2020
2.3.2 Analysis of Other Dosage Forms
3 Analysis of Major Meropenem Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Meropenem Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Sumitomo Dainippon Pharma Co Ltd
3.2.1 Enterprise Profile
3.2.2 Sales of MEPEM (Sumitomo Dainippon's Meropenem) in China
3.3 Shenzhen Haibin Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of PAINON (Shenzhen Haibin's Meropenem) in China
3.4 CSPC Ouyi Pharmaceutical Group Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of ShuLuoKe (CSPC Ouyi's Meropenem) in China
3.5 Hanhui Pharmaceuticals Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Haizhengmeite (Hanhui's Meropenem) in China
3.6 Haikou Pharmaceutical Factory Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Anjili (Haikou Pharmaceutical Factory's Meropenem) in China
4 Prices of Meropenem for Different Manufacturers in China, 2020-2021
4.1 Sumitomo Dainippon Pharma Co Ltd (MEPEM)
4.2 Shenzhen Haibin Pharmaceutical Co., Ltd. (PAINON)
4.3 CSPC Ouyi Pharmaceutical Group Co., Ltd. (ShuLuoKe)
4.4 Hanhui Pharmaceuticals Co., Ltd. (Haizhengmeite)
4.5 Haikou Pharmaceutical Factory Co., Ltd. (Anjili)
5 Prospect of Chinese Meropenem drug Market, 2021-2025
5.1 Influential Factors of Chinese Meropenem Market Development
5.1.1 The Impact of COVID-19 on Chinese Meropenem Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Meropenem Injection Registration in China
Chart Sales Value of Meropenem Injection over the World
Chart Sales Value of Meropenem Injection in China, 2016-2020
Chart Sales Value of Meropenem Injection in China by Regions, 2016-2020
Chart Sales Volume of Meropenem Injection in China, 2016-2020
Chart Sales Volume of Meropenem Injection in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Meropenem Manufacturers in China, 2016-2020
Chart Sales Value and Volume of MEPEM in China, 2016-2020
Chart Sales Value and Volume of PAINON in China, 2016-2020
Chart Sales Value and Volume of ShuLuoKe in China, 2016-2020
Chart Sales Value and Volume of Haizhengmeite, 2016-2020
Chart Sales Value and Volume of Anjili, 2016-2020
Chart Referential Prices of MEPEM in China, 2020-2021
Chart Referential Prices of PAINON in China, 2020-2021
Chart Referential Prices of ShuLuoKe in China, 2020-2021
Chart Referential Prices of Haizhengmeite in China, 2020-2021
Chart Referential Prices of Anjili in China, 2020-2021
Chart Forecast on Sales Value of Meropenem in China, 2021-2025
Chart Forecast on Sales Volume of Meropenem in China, 2021-2025
- CSPC Ouyi Pharmaceutical Group
- Haikou Pharmaceutical Factory
- Hanhui Pharmaceuticals
- Shenzhen Haibin Pharmaceutical
- Sumitomo Dainippon Pharma
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.